__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

Rate this content: 
Average: 5 (1 vote)
UK| July 2021 | 129283

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

Rate this content: 
Average: 4.3 (4 votes)
UK | March 2021 | 107321

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

Rate this content: 
Average: 5 (1 vote)
MUL20-E055 November 2020.

Watch Lucie’s MS story, and experience the transition to SPMS through a patient’s eyes.Show more

Rate this content: 
Average: 5 (1 vote)
SIP20-C001l November 2020.

_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________Show more

Rate this content: 
Average: 5 (1 vote)
MUL20-C025b October 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via uk.patientsafety@novartis.com or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at medinfo.uk@novartis.com